Hung Tseng to Cost-Benefit Analysis
This is a "connection" page, showing publications Hung Tseng has written about Cost-Benefit Analysis.
Connection Strength
0.236
-
Incremental clinical and economic impact of recombinant zoster vaccination: real-world data in a budget impact model. J Manag Care Spec Pharm. 2020 Dec; 26(12):1567-1575.
Score: 0.174
-
Varicella epidemiology and cost-effectiveness analysis of universal varicella vaccination program in Taiwan. Southeast Asian J Trop Med Public Health. 2005 Nov; 36(6):1450-8.
Score: 0.062